Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR - ICR / Cancer Research Society Partnership - Research Grants

University of British Columbia

$60,000.00

Development of a Liquid Biopsy for Early Breast Cancer Detection

FY 2021-22

Summary
Breast cancer is the most commonly diagnosed cancer amongst females in Canada. Screening for BCa is performed using mammography to detect lesions within the breast. However, mammography results in a significant overdiagnosis of BCa and cannot distinguish between cancerous and healthy tissue leading to false positive results of benign disease. In addition, mammography does not always accurately detect cancer, as such, it can lead to a misdiagnosis suggesting that an individual is healthy when in-fact they have a tumor that was not detected by mammography. This highlights the need for the development of a non-invasive, accurate, and informative breast cancer screening test to improve the detection of clinically relevant disease. Our work to date has profiled the protein content of small particles, called extracellular vesicles (EVs), found in the blood of breast cancer patients and healthy individuals. From this we have generated a signature or fingerprint of breast cancer. Our current work aims to validate these protein markers and determine the best way to detect them so that we can develop a simple blood test that would support detection of breast cancer at its earliest stage. By detecting breast cancer at its earliest stage, this will support the best long-term survival outcomes for any individual with a newly diagnosed breast cancer.
Program
CIHR - ICR / Cancer Research Society Partnership - Research Grants
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
468110
Name
Williams Karla
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Cancer Research Society Inc.; Cancer Research Society Inc.
Instname2
Cancer Research
Prcname2
Special Cases
Projecttitle
Development of a Liquid Biopsy for Early Breast Cancer Detection
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$60,000
Cihrequipment2
$0
Programname2
CIHR - ICR / Cancer Research Society Partnership - Research Grants
Keyworddelim
Breast Cancer; Targets And Biomarkers
Abstract
Breast cancer is the most commonly diagnosed cancer amongst females in Canada. Screening for BCa is performed using mammography to detect lesions within the breast. However, mammography results in a significant overdiagnosis of BCa and cannot distinguish between cancerous and healthy tissue leading to false positive results of benign disease. In addition, mammography does not always accurately detect cancer, as such, it can lead to a misdiagnosis suggesting that an individual is healthy when in-fact they have a tumor that was not detected by mammography. This highlights the need for the development of a non-invasive, accurate, and informative breast cancer screening test to improve the detection of clinically relevant disease. Our work to date has profiled the protein content of small particles, called extracellular vesicles (EVs), found in the blood of breast cancer patients and healthy individuals. From this we have generated a signature or fingerprint of breast cancer. Our current work aims to validate these protein markers and determine the best way to detect them so that we can develop a simple blood test that would support detection of breast cancer at its earliest stage. By detecting breast cancer at its earliest stage, this will support the best long-term survival outcomes for any individual with a newly diagnosed breast cancer.
Competitiondate
202202
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Williams, Karla
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Cancer Research~ $60,000~ $0~
University of British Columbia - $60,000 Grant (2021-… | Canada Spends